Suppr超能文献

乳腺癌中雌激素受体(ER)、孕激素受体(PR)和人表皮生长因子受体2(HER-2/neu,即C-erb B 2)反应模式与组织学分级、肿瘤大小及淋巴结状态的比较

Comparison of ER, PR and HER-2/neu (C-erb B 2) reactivity pattern with histologic grade, tumor size and lymph node status in breast cancer.

作者信息

Bhurgri Yasmin, Raza Farrukh, Kayani Naila

机构信息

Pathology-based Cancer Registry, Dept. of Pathology and Microbiology, Aga Khan University Hospital, Stadium Road PO Box 3500, Karachi 74800, Pakistan.

出版信息

Asian Pac J Cancer Prev. 2008 Oct-Dec;9(4):553-6.

Abstract

INTRODUCTION

Carcinoma of the breast is the most common malignancy of women in Karachi. The current study was conducted with the objective of assessing estrogen receptor (ER), progesterone receptor (PR) and HER-2/neu reactivity patterns of mammary cancers for correlation with histologic grade, tumor size and lymph node metastasis.

MATERIALS AND METHODS

One hundred and fifty modified mastectomy specimens received at the section of histopathology, Aga Khan University Hospital, were selected using a non-probability sampling method.

RESULTS

Mean age of the patients was 48.3 years (95%CI 46.5, 50.2). The left breast was more commonly involved (57%). Tumor size ranged from 0.3 to 15.0 cm; 12% were >2.0 and 35.3% were >5.0 cm in diameter. The predominant morphology was infiltrating ductal carcinoma (85.3%). The majority of the cases presented as grade II (55.3%) lesions with tumor necrosis (70%) and lymph node involvement (71.3%). ER and PR were positive in 32.7% and 25.3% cases respectively. HER-2/neu was positive (3+) in 24.7%. ER positivity increased and HER-2/neu positivity decreased with rising age. ER and PR expression was significantly lower in HER-2/neu positive as compared with HER-2/neu negative tumors (ER 83.8% vs 69.8%; PR 91.9% vs 77.8%). In the HER-2/neu positive tumors, ER and PR expression in high grade tumors was significantly decreased compared with intermediate grade tumors (ER 5.6% vs 10.5; PR 0% vs 5.3%). ER expression in the HER-2/neu positive, large sized tumors was also significantly decreased compared with smaller tumors (ER 6.3% vs 11.8).

CONCLUSIONS

ER and PR expression in breast cancers in the current study was found to be comparable to published international data, but the frequency of HER-2/neu expression was higher, possibly reflecting a young age at diagnosis. Assessment of prognostic markers for the clinical management of breast cancer patients is strongly advocated to provide best therapeutic options.

摘要

引言

乳腺癌是卡拉奇女性中最常见的恶性肿瘤。本研究旨在评估乳腺癌的雌激素受体(ER)、孕激素受体(PR)和HER-2/neu反应模式,以与组织学分级、肿瘤大小和淋巴结转移进行相关性分析。

材料与方法

采用非概率抽样方法,选取阿迦汗大学医院组织病理学切片接收的150例改良乳房切除术标本。

结果

患者的平均年龄为48.3岁(95%可信区间46.5, 50.2)。左侧乳房受累更为常见(57%)。肿瘤大小范围为0.3至15.0厘米;12%的肿瘤直径>2.0厘米,35.3%的肿瘤直径>5.0厘米。主要形态为浸润性导管癌(85.3%)。大多数病例表现为II级(55.3%)病变,伴有肿瘤坏死(70%)和淋巴结受累(71.3%)。ER和PR分别在32.7%和25.3%的病例中呈阳性。HER-2/neu呈阳性(3+)的病例占24.7%。随着年龄增长,ER阳性率增加,HER-2/neu阳性率降低。与HER-2/neu阴性肿瘤相比,HER-2/neu阳性肿瘤中的ER和PR表达显著降低(ER 83.8%对69.8%;PR 91.9%对77.8%)。在HER-2/neu阳性肿瘤中,高级别肿瘤的ER和PR表达与中级别肿瘤相比显著降低(ER 5.6%对10.5;PR 0%对5.3%)。与较小肿瘤相比,HER-2/neu阳性的大尺寸肿瘤中的ER表达也显著降低(ER 6.3%对11.8)。

结论

本研究中乳腺癌的ER和PR表达与已发表的国际数据相当,但HER-2/neu表达频率较高,这可能反映了诊断时的年轻年龄。强烈建议评估乳腺癌患者临床管理的预后标志物,以提供最佳治疗选择。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验